The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-activating factor (PAF)

被引:212
作者
Smith, PF
Maclennan, K
Darlington, CL
机构
[1] UNIV OTAGO,DEPT PSYCHOL,DUNEDIN,NEW ZEALAND
[2] UNIV OTAGO,NEUROSCI RES CTR,DUNEDIN,NEW ZEALAND
关键词
Ginkgo biloba; ginkgolides; neuroprotection; neural damage; TRANSCRIPTIONAL SIGNALING SYSTEM; LONG-TERM POTENTIATION; RAT-BRAIN; ELECTROCONVULSIVE SHOCK; FACTOR ANTAGONISTS; CEREBRAL-CORTEX; BINDING-SITES; FATTY-ACIDS; BLOOD-FLOW; EGB; 761;
D O I
10.1016/0378-8741(96)01379-7
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ginkgo biloba (Ginkgoaceae) is an ancient Chinese tree which has been cultivated and held sacred for its health-promoting properties. There is substantial experimental evidence to support the view that Ginkgo biloba extracts have neuroprotective properties under conditions such as hypoxia/ischemia, seizure activity and peripheral nerve damage. Research on the biochemical effects of Ginkgo biloba extracts is still at a very early stage. One of the components of Ginkgo biloba, ginkgolide B, is a potent platelet-activating factor (PAF) antagonist. Although the terpene fraction of Ginkgo biloba, which contains the ginkgolides, may contribute to the neuroprotective properties of the Ginkgo biloba leaf, it is also likely that the flavonoid fraction, containing free radical scavengers, is important in this respect. Taken together, the evidence suggests that Ginkgo biloba extracts are worthy of further investigation as potential neuroprotectant agents.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 62 条
[1]   GINKGO-BILOBA EXTRACT FACILITATES RECOVERY FROM PENETRATING BRAIN INJURY IN ADULT MALE-RATS [J].
ATTELLA, MJ ;
HOFFMAN, SW ;
STASIO, MJ ;
STEIN, DG .
EXPERIMENTAL NEUROLOGY, 1989, 105 (01) :62-71
[2]   PLATELET-ACTIVATING-FACTOR AND POLYUNSATURATED FATTY-ACIDS IN CEREBRAL-ISCHEMIA OR CONVULSIONS - INTRACELLULAR PAF-BINDING SITES AND ACTIVATION OF A FOS/JUN/AP-1 TRANSCRIPTIONAL SIGNALING SYSTEM [J].
BAZAN, NG ;
SQUINTO, SP ;
BRAQUET, P ;
PANETTA, T ;
MARCHESELLI, VL .
LIPIDS, 1991, 26 (12) :1236-1242
[3]  
BEEK TA, 1991, J CHROMATOGR, V543, P375
[4]   LEUKOCYTE-DEPENDENT HISTAMINE-RELEASE FROM RABBIT PLATELETS - ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR [J].
BENVENISTE, J ;
HENSON, PM ;
COCHRANE, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) :1356-+
[5]   INFARCT REDUCTION BY THE PLATELET-ACTIVATING-FACTOR ANTAGONIST APAFANT IN RATS [J].
BIELENBERG, GW ;
WAGENER, G ;
BECK, T .
STROKE, 1992, 23 (01) :98-103
[6]   PLATELET-ACTIVATING FACTOR ANTAGONIST BN52021 DECREASES ACCUMULATION OF FREE POLY-UNSATURATED FATTY-ACID IN MOUSE-BRAIN DURING ISCHEMIA AND ELECTROCONVULSIVE SHOCK [J].
BIRKLE, DL ;
KURIAN, P ;
BRAQUET, P ;
BAZAN, NG .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) :1900-1905
[7]   EFFECT OF PLATELET-ACTIVATING FACTOR ON HYPOTHALAMIC AND HYPOPHYSEAL PRO-OPIOMELANOCORTIN-RELATED PEPTIDES AND HYPOTHALAMOPITUITARY-ADRENAL AXIS IN THE RAT [J].
BLASQUEZ, C ;
JEGOU, S ;
DELARUE, C ;
DELBENDE, C ;
BUNEL, DT ;
BRAQUET, P ;
VAUDRY, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 177 (03) :145-153
[8]   A SYNAPTIC MODEL OF MEMORY - LONG-TERM POTENTIATION IN THE HIPPOCAMPUS [J].
BLISS, TVP ;
COLLINGRIDGE, GL .
NATURE, 1993, 361 (6407) :31-39
[9]  
BRAILOWSKY S, 1995, RESTOR NEUROL NEUROS, V8, P163, DOI 10.3233/RNN-1995-8401
[10]  
BRAILOWSKY S, 1993, SOC NEUR ABSTR, V2, P1013